IBB / Biotech will face challenges this year, says Jefferies' Michael Yee

Most of you know our Big View product, since I often talk about our risk gauges. In fact, I can report to you that our risk gauges show 3 out of the more_horizontal

The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Healt more_horizontal

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF (IBB) is a passively manage more_horizontal

The biotechnology sector has disappointed overall; we think there are better ways to get exposure to the healthcare sector. iShares Biotechnology ETF more_horizontal

Biotechnology has traded basically sideways since the start of 2023. In the face of higher rates, stronger dollar, inflation, FDA approvals and busts, more_horizontal

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health more_horizontal

Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the He more_horizontal

Shares of PaxMedia Inc. PXMD, -11.91% bounced 2.0% in premarket trading Thursday, after the biopharmaceutical company, which focuses on treatments of more_horizontal